SyntheMol-RL: a flexible reinforcement learning framework for designing easily synthesizable antibiotics
Open Access
- 23 April 2026
- journal article
- research article
- Published by Springer Nature in Molecular Systems Biology
- Vol. 22 (6) , 833-867
Abstract
The rise of antibiotic-resistant pathogens such as Staphylococcus aureus has created an urgent need for new antibiotics. Generative artificial intelligence (AI) has shown promise in drug discovery, but existing models often fail to propose compounds that are both effective and synthetically tractable. To address these challenges, we introduce SyntheMol-RL, a reinforcement learning-based generative model that can rapidly design synthetically accessible small-molecule drug candidates from a massive chemical space of 46 billion compounds. SyntheMol-RL improves upon our prior Monte Carlo tree search (MCTS)-based SyntheMol model by generalizing across chemically similar building blocks and enabling multi-parameter optimization. We applied SyntheMol-RL to generate candidate antibiotics against S. aureus by optimizing for both antibacterial activity and aqueous solubility, and we found that SyntheMol-RL generated molecules with improved predicted properties compared to both the previous MCTS version of SyntheMol as well as an AI-based virtual screening baseline. We synthesized 79 SyntheMol-RL compounds that were unique relative to the training dataset and found that 13 showed potent in vitro activity, of which seven passed our structural novelty filters that compared them to known antibiotics. Furthermore, one hit compound, synthecin, demonstrated efficacy in a murine wound infection model of methicillin-resistant S. aureus (MRSA). These results validate SyntheMol-RL’s ability to generate synthetically accessible candidate antibiotics and position SyntheMol-RL as a powerful tool for drug design across therapeutic domains.Keywords
Funding Information
- Weston Family Foundation
- David Braley Centre for Antibiotic Discovery
- Canadian Institutes of Health Research (PJT 186281)
- Natural Sciences and Engineering Research Council of Canada
- M. and M. Heersink
- Chan Zuckerberg Initiative
- Knight-Hennessy Scholarship
- Stanford Bio-X
- Canada Research Chairs
This publication has 57 references indexed in Scilit:
- A generative deep learning approach to de novo antibiotic designCell, 2025
- Unleashing the power of generative AI in drug discoveryDrug Discovery Today, 2024
- Molecular Generative Model via Retrosynthetically Prepared Chemical Building Block AssemblyAdvanced Science, 2023
- Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trialClinical and Translational Medicine, 2022
- Generative models for molecular discovery: Recent advances and challengesWIREs Computational Molecular Science, 2022
- Generative chemistry: drug discovery with deep learning generative modelsJournal of Molecular Modeling, 2021
- Generating Multibillion Chemical Space of Readily Accessible Screening CompoundsiScience, 2020
- A Deep Learning Approach to Antibiotic DiscoveryCell, 2020
- Efficient Selectivity and Backup Operators in Monte-Carlo Tree Search2007
- Bandit Based Monte-Carlo Planning2006